{"nct_id":"NCT02387125","title":"Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1","status":"TERMINATED","status_verified_date":"2020-06","start_date":"2015-02-28","start_date_type":"ACTUAL","primary_completion_date":"2019-03-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-03-29","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}